Chemical Communications: Developing a vaccine for street drug xylazine

Researchers are developing a vaccine which blocks the toxic effects of the drug xylazine, a drug which has been a cause of many overdose deaths in the illicit drug trade in the USA and the UK.  

The vaccine has worked in mice, although no human trials have been undertaken. The study findings have been published in the journal Chemical Communications.